ShiraTronics announced it initiated its FDA investigational device exemption (IDE) pivotal trial for its neuromodulation therapy. The RELIEV-CM2 clinical study evaluates the company’s neuromodulation...
Nervonik announced it completed the first-in-human clinical study of its peripheral nerve stimulation (PNS) device.
The Los Angeles-based startup designed its proprietary device to enhance...
The regulatory study validated Remplir as a safe and effective biological medical device for use in the surgical repair of peripheral nerves and will...
BrioHealth Solutions enroled its first patients in the U.S. for the INNOVATE trial of its BrioVAD system. Burlington, Massachusetts–based BrioHealth has had its BrioVAD...
EmStop has completed the ‘Controlled Arterial Protection to Ultimately Remove Embolic Material’ (CAPTURE-1) early feasibility clinical study which assessed the EmStop embolic protection system.
The...
Supira Medical began patient enrolment in a U.S. early feasibility trial of its percutaneous ventricular assist device (pVAD).
The Shifamed portfolio company plans to evaluate...
EndoTheia completed the first-in-human clinical trial for its FlexStone basket, a steerable kidney stone treatment. Nashville, Tennessee-based EndoTheia said its FlexStone basket represents the...
Second Heart Assist announced successful case studies in South America with its Whisper catheter-delivered heart assist device. Dr. Adrian Ebner, head of the cardiovascular...
Tivic Health Systems completed enrollment in a study for its vagus nerve stimulation (VNS) device.
The study, conducted by The Feinstein Institute of Bioelectronic Medicine,...
